Syensqo/€SYENS
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Syensqo
Syensqo SA is a Belgium-based company specializing in the chemical sector. The company focuses on developing sustainable chemical solutions including specialty polymers, composite materials, and bio-circular chemistries. It aims to support its clients by providing innovative materials to advance in lightweight and performance-focused manufacturing processes.
- Ticker
- €SYENS
- Sector
- Materials
- Primary listing
- BSE
- Employees
- 13,000
- Headquarters
- Brussels, Belgium
- Website
- www.syensqo.com
Syensqo Metrics
BasicAdvanced
€8.1B
-
-€0.24
0.49
€1.13
1.42%
Price and volume
Market cap
€8.1B
Beta
0.49
52-week high
€83.30
52-week low
€41.91
Average daily volume
151K
Dividend rate
€1.13
Financial strength
Current ratio
1.646
Quick ratio
1.023
Long term debt to equity
0.39
Total debt to equity
0.456
Interest coverage (TTM)
3.00%
Profitability
EBITDA (TTM)
1,288
Gross margin (TTM)
30.89%
Net profit margin (TTM)
-0.39%
Operating margin (TTM)
7.01%
Effective tax rate (TTM)
205.88%
Revenue per employee (TTM)
€460,000
Management effectiveness
Return on assets (TTM)
3.06%
Return on equity (TTM)
-1.01%
Valuation
Price to revenue (TTM)
1.356
Price to book
1.34
Price to tangible book (TTM)
3.71
Price to free cash flow (TTM)
21.691
Free cash flow yield (TTM)
4.61%
Free cash flow per share (TTM)
3.684
Dividend yield (TTM)
1.42%
Forward dividend yield
1.42%
Growth
Revenue change (TTM)
-0.51%
Earnings per share change (TTM)
-71.24%
3-year revenue growth (CAGR)
-8.85%
3-year earnings per share growth (CAGR)
-67.47%
What the Analysts think about Syensqo
Analyst ratings (Buy, Hold, Sell) for Syensqo stock.
Analyst projections of the future price of Syensqo stock.
Bulls say / Bears say
Syensqo returned to growth in Q2, with organic sales up 5% and gross margin rising to 34%. Management lifted its 2026 EBITDA outlook to at least €1.1 billion, backed by improving order books and expected low-to-mid-single-digit volume growth. (Syensqo)
Aerospace demand is providing a tangible growth engine: Composite Materials sales rose 18% in Q2, and a new multi-year Airbus agreement secures supply across commercial, defence and space programmes. Syensqo is also expanding US production capacity to serve growing aerospace demand. (Syensqo, Syensqo)
A review of Performance & Care could sharpen Syensqo’s focus on specialty materials and advanced technologies, while creating scope to realise value from the business. Management says it has appointed advisers to consider how best to maximise long-term shareholder value. (Syensqo)
The sales recovery has not yet translated into stronger underlying earnings: Q2 EBITDA fell 6% year on year to €311 million and its margin declined to 20%. Selective pricing and higher performance-improvement costs weighed on Specialty Polymers. (Syensqo, EarningsCalls.dev)
The recovery remains exposed to a difficult and uncertain backdrop. Management expects only a gradual volume recovery through the rest of 2026 and flags geopolitical uncertainty, leaving its growth outlook dependent on demand improving as anticipated. (Syensqo)
Cash generation may remain constrained by investment needs: Syensqo still expects about €450 million of 2026 capital expenditure against roughly €700 million of operating cash flow. Q2 cash flow also benefited from the absence of separation costs and positive working capital, so that quarter’s improvement may not be a simple recurring run-rate. (Syensqo)
Data summarised monthly by Lightyear AI. Last updated on 4 Oct 2026.
Syensqo Financial Performance
Revenues and expenses
Syensqo Earnings Performance
Company profitability
Upcoming events
No upcoming events
Funds containing Syensqo
AllEURGBPUSD
Fund name | Fund size | €SYENS weighting |
|---|---|---|
iShares STOXX Europe 600 Chemicals€EXV7 | €104M | 2.59% |
iShares EURO STOXX Mid€DJMC | €572M | 0.71% |
iShares EURO STOXX Mid Cap£DJMC | £491M | 0.71% |
iShares STOXX Europe Mid 200€EXSD | €610M | 0.35% |
SPDR MSCI World Materials€WMAT | €198M | 0.22% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.